Stock listing

0HNC Stock Price, News, Filings & Events — Biomarin Pharmaceutical Inc.

Selected listing: 0HNC · LSE · USD · GB

The selected listing for Biomarin Pharmaceutical Inc. is 0HNC:LSE. Biomarin is a biotechnology company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. Recent news highlights their ongoing clinical trials and regulatory filings aimed at advancing their product pipeline. Investors can stay updated on upcoming events and market developments that may impact the company's performance.

0HNC:LSEUSDGBUpdated July 20, 2026
Biomarin Pharmaceutical Inc. logo
Ticker
0HNC:LSE
Asset type
Stock
Market cap
$11.40B
Sector
Health Technology
Industry
Biotechnology
Exchange
LSE
Currency
USD

Biomarin Pharmaceutical Inc. 0HNC:LSE stock context

The selected listing for Biomarin Pharmaceutical Inc. is 0HNC:LSE. Biomarin is a biotechnology company focused on developing innovative biopharmaceuticals for serious diseases and medical conditions. Recent news highlights their ongoing clinical trials and regulatory filings aimed at advancing their product pipeline. Investors can stay updated on upcoming events and market developments that may impact the company's performance.

Research Biomarin Pharmaceutical Inc.

Alternate listings